This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/520588-vaccine-janssen-investigation-eu-blood-clots/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 1 | Version 2 |
|---|---|
| Johnson & Johnson’s Covid-19 vaccine under investigation in EU over potential link to ‘unusual’ blood clots | Johnson & Johnson’s Covid-19 vaccine under investigation in EU over potential link to ‘unusual’ blood clots |
| (about 1 month later) | |
| The European Union’s drug regulator EMA says it will assess Johnson & Johnson’s Covid-19 Vaccine Janssen after “four serious cases of unusual blood clots” occurred in people who received the jab in the US. | The European Union’s drug regulator EMA says it will assess Johnson & Johnson’s Covid-19 Vaccine Janssen after “four serious cases of unusual blood clots” occurred in people who received the jab in the US. |
| The statement from EMA’s Pharmacovigilance Risk Assessment Committee says one case occurred in a clinical trial and three others during the vaccine rollout in the US. One of the cases was fatal. | The statement from EMA’s Pharmacovigilance Risk Assessment Committee says one case occurred in a clinical trial and three others during the vaccine rollout in the US. One of the cases was fatal. |
| Covid-19 vaccine Janssen is currently only used in the USA but the rollout in the EU is expected within the next few weeks. The EMA authorised the jab for use in the EU in March. The agency says the cases are being investigated and currently it’s not clear whether the incidents of blood clots are connected to the vaccinations. | Covid-19 vaccine Janssen is currently only used in the USA but the rollout in the EU is expected within the next few weeks. The EMA authorised the jab for use in the EU in March. The agency says the cases are being investigated and currently it’s not clear whether the incidents of blood clots are connected to the vaccinations. |
| Earlier this week the EMA published a review of AstraZeneca’s Covid-19 Vaxzevria vaccine, announcing that ‘unusual’ blood clots were ‘very rare side effects’ of the jab. Several EU countries suspended the use of the vaccine. The EMA said that 18 people had died of blood clots after receiving the Anglo-Swedish vaccine. | Earlier this week the EMA published a review of AstraZeneca’s Covid-19 Vaxzevria vaccine, announcing that ‘unusual’ blood clots were ‘very rare side effects’ of the jab. Several EU countries suspended the use of the vaccine. The EMA said that 18 people had died of blood clots after receiving the Anglo-Swedish vaccine. |
| Think your friends would be interested? Share this story! | Think your friends would be interested? Share this story! |